Barrett, J. A., Coleman, R., Morse, M., Borys, N., Kronauge, J., Stubbs, J. B., … Babich, J. W. (2007). Phase 1 study of radiation dosimetry and clearance of no carrier added 131I-MIBG (ultratrace iobenguane) in 7 carcinoid and 4 pheochromocytoma patients. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (Vol. 34, pp. S241–S241). Copenhagen, DENMARK: SPRINGER.

Barrett, J. A., R. Coleman, M. Morse, N. Borys, J. Kronauge, J. B. Stubbs, H. Mok, et al. “Phase 1 study of radiation dosimetry and clearance of no carrier added 131I-MIBG (ultratrace iobenguane) in 7 carcinoid and 4 pheochromocytoma patients.” In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 34:S241–S241. SPRINGER, 2007.

Barrett JA, Coleman R, Morse M, Borys N, Kronauge J, Stubbs JB, et al. Phase 1 study of radiation dosimetry and clearance of no carrier added 131I-MIBG (ultratrace iobenguane) in 7 carcinoid and 4 pheochromocytoma patients. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2007. p. S241–S241.

Barrett, J. A., et al. “Phase 1 study of radiation dosimetry and clearance of no carrier added 131I-MIBG (ultratrace iobenguane) in 7 carcinoid and 4 pheochromocytoma patients.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 34, SPRINGER, 2007, pp. S241–S241.

Barrett JA, Coleman R, Morse M, Borys N, Kronauge J, Stubbs JB, Mok H, Qi F, Petry NN, Vaidyanathan G, Babich JW. Phase 1 study of radiation dosimetry and clearance of no carrier added 131I-MIBG (ultratrace iobenguane) in 7 carcinoid and 4 pheochromocytoma patients. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2007. p. S241–S241.